| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ImmunoGen, Inc. | SVP & CHIEF COMMERCIAL OFFICER | Restricted Stock Unit | 0 | $0 | $29.30 | Feb 12, 2024 | Direct |
| ImmunoGen, Inc. | SVP & CHIEF COMMERCIAL OFFICER | Stock Option (Right to Buy) | 0 | $0 | $5.19 | Feb 12, 2024 | Direct |
| Crinetics Pharmaceuticals, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 100K | Jan 10, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals, Inc. | Jan 10, 2025 | 1 | $0 | 4 | Jan 13, 2025 | Chief Commercial Officer |
| CRNX | Crinetics Pharmaceuticals, Inc. | Dec 16, 2024 | 0 | $0 | 3 | Dec 30, 2024 | Chief Commercial Officer |
| IMGN | ImmunoGen, Inc. | Feb 12, 2024 | 3 | $0 | 4 | Feb 12, 2024 | SVP & CHIEF COMMERCIAL OFFICER |
| IMGN | ImmunoGen, Inc. | Feb 1, 2024 | 1 | $0 | 4 | Feb 5, 2024 | SVP & CHIEF COMMERCIAL OFFICER |
| IMGN | ImmunoGen, Inc. | Apr 28, 2023 | 2 | $0 | 4 | May 2, 2023 | SVP & CHIEF COMMERCIAL OFFICER |
| IMGN | ImmunoGen, Inc. | Apr 24, 2023 | 0 | $0 | 3 | May 2, 2023 | SVP & CHIEF COMMERCIAL OFFICER |